MENU
+Compare
ICAD
Stock ticker: NASDAQ
AS OF
Apr 17, 04:59 PM (EDT)
Price
$3.22
Change
+$0.15 (+4.89%)
Capitalization
42.43M

ICAD iCAD Forecast, Technical & Fundamental Analysis

icad Inc is a medical technology company providing cancer detection and therapy solutions... Show more

ICAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ICAD with price predictions
Apr 16, 2025

Momentum Indicator for ICAD turns positive, indicating new upward trend

ICAD saw its Momentum Indicator move above the 0 level on April 16, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ICAD just turned positive on April 15, 2025. Looking at past instances where ICAD's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

ICAD moved above its 50-day moving average on April 16, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +6 3-day Advance, the price is estimated to grow further. Considering data from situations where ICAD advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICAD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ICAD broke above its upper Bollinger Band on April 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ICAD entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.274) is normal, around the industry mean (23.907). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.499) is also within normal values, averaging (42.115).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ICAD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICAD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
ICAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ICAD is expected to report earnings to rise 94.33% to -5 cents per share on May 19

iCAD ICAD Stock Earnings Reports
Q1'25
Est.
$-0.06
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.07
Q1'24
Beat
by $0.01
The last earnings report on March 19 showed earnings per share of -2 cents, beating the estimate of -5 cents. With 665.51K shares outstanding, the current market capitalization sits at 42.43M.
A.I. Advisor
published General Information

General Information

a provider of computer-aided detection solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
98 Spit Brook Road
Phone
+1 603 882-5200
Employees
109
Web
https://www.icadmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X84033.870000364.875000
+0.44%
Bitcoin cryptocurrency
GME26.25-0.45
-1.69%
GameStop Corp
SPY525.66-11.95
-2.22%
SPDR® S&P 500® ETF
AAPL194.27-7.87
-3.89%
Apple
TSLA241.55-12.56
-4.94%
Tesla

ICAD and Stocks

Correlation & Price change

A.I.dvisor tells us that ICAD and KRMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ICAD and KRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICAD
1D Price
Change %
ICAD100%
+59.07%
KRMD - ICAD
31%
Poorly correlated
-4.58%
HYPR - ICAD
29%
Poorly correlated
-4.39%
BLFS - ICAD
28%
Poorly correlated
-0.76%
AVNS - ICAD
28%
Poorly correlated
+0.25%
NEO - ICAD
28%
Poorly correlated
+0.63%
More